Literature DB >> 18992671

American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.

Sharon L Mulvagh1, Harry Rakowski, Mani A Vannan, Sahar S Abdelmoneim, Harald Becher, S Michelle Bierig, Peter N Burns, Ramon Castello, Patrick D Coon, Mary E Hagen, James G Jollis, Thomas R Kimball, Dalane W Kitzman, Itzhak Kronzon, Arthur J Labovitz, Roberto M Lang, Joseph Mathew, W Stuart Moir, Sherif F Nagueh, Alan S Pearlman, Julio E Perez, Thomas R Porter, Judy Rosenbloom, G Monet Strachan, Srihari Thanigaraj, Kevin Wei, Anna Woo, Eric H C Yu, William A Zoghbi.   

Abstract

UNLABELLED: ACCREDITATION STATEMENT: The American Society of Echocardiography (ASE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASE designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit.trade mark Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Registry of Diagnostic Medical Sonographers and Cardiovascular Credentialing International recognize the ASE's certificates and have agreed to honor the credit hours toward their registry requirements for sonographers. The ASE is committed to resolving all conflict-of-interest issues, and its mandate is to retain only those speakers with financial interests that can be reconciled with the goals and educational integrity of the educational program. Disclosure of faculty and commercial support sponsor relationships, if any, have been indicated. TARGET AUDIENCE: This activity is designed for all cardiovascular physicians, cardiac sonographers, and nurses with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, sonographers, and other medical professionals having a specific interest in contrast echocardiography may be included.
OBJECTIVES: Upon completing this activity, participants will be able to: 1. Demonstrate an increased knowledge of the applications for contrast echocardiography and their impact on cardiac diagnosis. 2. Differentiate the available ultrasound contrast agents and ultrasound equipment imaging features to optimize their use. 3. Recognize the indications, benefits, and safety of ultrasound contrast agents, acknowledging the recent labeling changes by the US Food and Drug Administration (FDA) regarding contrast agent use and safety information. 4. Identify specific patient populations that represent potential candidates for the use of contrast agents, to enable cost-effective clinical diagnosis. 5. Incorporate effective teamwork strategies for the implementation of contrast agents in the echocardiography laboratory and establish guidelines for contrast use. 6. Use contrast enhancement for endocardial border delineation and left ventricular opacification in rest and stress echocardiography and unique patient care environments in which echocardiographic image acquisition is frequently challenging, including intensive care units (ICUs) and emergency departments. 7. Effectively use contrast echocardiography for the diagnosis of intracardiac and extracardiac abnormalities, including the identification of complications of acute myocardial infarction. 8. Assess the common pitfalls in contrast imaging and use stepwise, guideline-based contrast equipment setup and contrast agent administration techniques to optimize image acquisition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992671     DOI: 10.1016/j.echo.2008.09.009

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  98 in total

1.  Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study.

Authors:  Omar Wever-Pinzon; Valentin Suma; Ameeta Ahuja; Jorge Romero; Nishtha Sareen; Sonia A Henry; Maria De Benedetti Zunino; Farhan F Chaudhry; Ramya S Suryadevara; Mark V Sherrid; Farooq A Chaudhry
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-03-16       Impact factor: 6.875

Review 2.  Contrast echocardiography: what have we learned from the new guidelines?

Authors:  Kevin Wei
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

3.  Determination of postexcitation thresholds for single ultrasound contrast agent microbubbles using double passive cavitation detection.

Authors:  Daniel A King; Michael J Malloy; Alayna C Roberts; Alexander Haak; Christian C Yoder; William D O'Brien
Journal:  J Acoust Soc Am       Date:  2010-06       Impact factor: 1.840

Review 4.  Novel techniques for assessment of left ventricular systolic function.

Authors:  Sonal Chandra; Hicham Skali; Ron Blankstein
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

5.  Assessment of tissue perfusion by contrast-enhanced ultrasound.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2010-10-07       Impact factor: 5.315

6.  Individual lipid encapsulated microbubble radial oscillations: Effects of fluid viscosity.

Authors:  Brandon Helfield; Xucai Chen; Bin Qin; Flordeliza S Villanueva
Journal:  J Acoust Soc Am       Date:  2016-01       Impact factor: 1.840

Review 7.  [Assessment of systolic function in patients with poor echogenicity: echocardiographic methods].

Authors:  F Weidemann; D Liu; M Niemann; S Herrmann; H Hu; P D Gaudron; G Ertl; K Hu
Journal:  Herz       Date:  2013-08-15       Impact factor: 1.443

8.  Clinical application and laboratory protocols for performing contrast echocardiography.

Authors:  Adrian Chong; Brian Haluska; Sudhir Wahi
Journal:  Indian Heart J       Date:  2013-04-06

Review 9.  [Assessment of diastolic heart failure. Current role of echocardiography].

Authors:  F Weidemann; M Niemann; S Herrmann; G Ertl; S Störk
Journal:  Herz       Date:  2013-02       Impact factor: 1.443

10.  Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.

Authors:  Kamran Shaikh; Dee Dee Wang; Hani Saad; Mohsin Alam; Akshay Khandelwal; Kristen Brooks; Hari Iyer; Phuc Nguyen; Stephanie Boedeker; Karthik Ananthasubramaniam
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-25       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.